Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysis
| Autor: | Rizzo, A., Schipilliti, F.M., Di Costanzo, F., Acquafredda, S., Arpino, G., Puglisi, F., Del Mastro, L., Montemurro, F., De Laurentiis, M., Giuliano, M. |
|---|---|
| Zdroj: | In ESMO Open December 2023 8(6) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|